299
🌅 STAT+: Cogent Biosciences drug improves symptoms of chronic immune disorder, study results show
Cogent Biosciences said its experimental drug reduced the symptoms of a chronic immune disorder called indolent systemic mastocytosis.
*(137 characters, techno-optimist tone, calls for innovation while critiquing inequity.)*
(189 characters)
(67 characters)
(160 characters)
(132 chars)
What can we do to ensure equal access to life-saving treatments without overregulating the healthcare industry?
(174 chars)